Font Size: a A A
Keyword [Topoisomerase II]
Result: 1 - 20 | Page: 1 of 2
1. Research On Molecule-mechanism Of Lung Cancer Multidrug Resistance
2. Establishment Of An Etoposide-resistant Human Small Cell Lung Cancer Cell Line H446/VP And Study On Its Drug Resistant Mechanism And Reversal
3. Transcription Factors Sp1 And Sp3 Influence K562 Leukemia Cell Proliferation, Apoptosis And Drug Resistance
4. Studies On The Antitumor Activity And Mechanism Of A Citrinin Trimer, Tricitrinol B
5. Prognostic Significance Of Topoisomerase II Alpha In Patients With Glioma
6. Study On The Mechanisms Of Arsenic Trioxide (As2O3) Induced Apoptosis Of Retinoic Acid Resistant Acute Promyelocytic Leukemia MR2 Cells.
7. A Study On The Expression Of P-gp ,GST-Ï€and Topo-â…¡ Proteins In Primary Epithelial Ovarian Cancer And Their Relationship With ATP-tumor Chemosensitivity Assay
8. The Influences Of Cisplatin On Tineposide Killing The Small Cell Lung Cancer Cells
9. Expression And Clinical Significance Of P-gp,TOPOâ…¡,GST-Ï€ And LRP In Breast Cancer
10. The Role Of Sp1 Up-expression In Drug Resistance Of The Small Cell Lung Cancer Cells
11. The Mechanisms Of Paclitaxel And The Effect Of Paclitaxel-based Multidrug Combinations On Inhibiting SKOV3 Ovarian Cancer Cells
12. Experimental Study On The Anti-leukemic Effects Of GP-7 In K562 And K562/ADM Cells
13. Study On Reversion Multidrug Resistance Effects And Mechanism Of Bushen Huayu Jiedu Recipe In Lung Cancer
14. Study On Expression Of P-gp, TopoⅡα And Their Related Factors In Primary Hepatocellular Carcinoma
15. Studies On Antitumor Activities And Mechanisms Of Triptolide And YCH337,both Of Which Overcome Tumor Drug Resistance
16. The Synthesis And Biological Activity Of Bisindolylalkanes, β-aminoketones And Thioethers
17. TOP2α Overexpression And Its Association With Clinicopathological Features And Prognosis In Gastric Cancer After R0 Resection
18. Topoisomerase II beta negatively modulates retinoic acid receptor alpha function: A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia
19. Domain communication in DNA topoisomerase II
20. Topoisomerase II inhibitors induce an illegitimate genome rearrangement common in infant leukemia
  <<First  <Prev  Next>  Last>>  Jump to